Human mucin MUC1 RNA undergoes different types of alternative splicing resulting in multiple isoforms

Cancer Immunology, Immunotherapy

Volumn 62, Issue 3, 2013, Pages 423-435

  Zhang, Lixin ^a   Vlad, Anda ^a   Milcarek, Christine ^a   Finn, Olivera J ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Alternative splicing; Isoforms; MUC1; Tumor

Indexed keywords

ISOPROTEIN; K RAS PROTEIN; MUCIN 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RNA ISOFORM; RNA;

ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRAIN MCF 7; CELL TRANSFORMATION; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SELECTION; GENETIC VARIABILITY; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; INTRON; LEUKEMIA CELL LINE; MOLECULAR CLONING; MOLECULAR RECOGNITION; MOUSE; MUCIN 1 GENE; MUTATIONAL ANALYSIS; MUTATOR GENE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; PRIORITY JOURNAL; PTEN GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA GENE; RNA ISOLATION; RNA SEQUENCE; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE ACTIVATION; VARIABLE NUMBER OF TANDEM REPEAT; ANIMAL; CELL LINE; CHEMISTRY; GENETICS; METABOLISM; T LYMPHOCYTE; TUMOR CELL LINE;

ALTERNATIVE SPLICING; ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EXONS; HUMANS; MICE; MINISATELLITE REPEATS; MUCIN-1; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN ISOFORMS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; T-LYMPHOCYTES;

MLCS; MLOWN;

EID: 84877101119     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-012-1325-2     Document Type: Article

References (63)

1. Modrek B, Lee C (2002) A genomic view of alternative splicing. Nat Genet 30(1):13-19
2. Johnson JM, Castle J, Garrett-Engele P, Kan Z, Loerch PM, Armour CD, Santos R, Schadt EE, Stoughton R, Shoemaker DD (2003) Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays. Science 302(5653):2141-2144 (Pubitemid 38017950)
3. Xing Y, Lee C (2006) Alternative splicing and RNA selection pressure-evolutionary consequences for eukaryotic genomes. Nat Rev Genet 7(7):499-509 (Pubitemid 43943568)
4. Blencowe BJ (2006) Alternative splicing: new insights from global analyses. Cell 126(1):37-47 (Pubitemid 44040990)
5. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 40(12):1413-1415
6. Wang ET, Sandberg R, Luo S, Khrebtukova I, Zhang L, Mayr C, Kingsmore SF, Schroth GP, Burge CB (2008) Alternative isoform regulation in human tissue transcriptomes. Nature 456(7221):470-476 (Pubitemid 352759009)
7. Nilsen TW, Graveley BR (2010) Expansion of the eukaryotic proteome by alternative splicing. Nature 463(7280):457-463
8. Stamm S (2002) Signals and their transduction pathways regulating alternative splicing: a new dimension of the human genome. Hum Mol Genet 11(20):2409-2416 (Pubitemid 35174704)
9. Faustino NA, Cooper TA (2003) Pre-mRNA splicing and human disease. Genes Dev 17(4):419-437 (Pubitemid 36258756)
10. Garcia-Blanco MA, Baraniak AP, Lasda EL (2004) Alternative splicing in disease and therapy. Nat Biotechnol 22(5):535-546 (Pubitemid 38585905)
11. Pagani F, Baralle FE (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet 5(5):389-396 (Pubitemid 38529410)
12. Venables JP (2004) Aberrant and alternative splicing in cancer. Cancer Res 64(21):7647-7654 (Pubitemid 39446889)
13. Pajares MJ, Ezponda T, Catena R, Calvo A, Pio R, Montuenga LM (2007) Alternative splicing: an emerging topic in molecular and clinical oncology. Lancet Oncol 8(4):349-357 (Pubitemid 46464532)
14. Wang GS, Cooper TA (2007) Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet 8(10):749-761 (Pubitemid 47429207)
15. Kim E, Goren A, Ast G (2008) Insights into the connection between cancer and alternative splicing. Trends Genet 24(1):7-10 (Pubitemid 350298628)
16. Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90(1-2):41-54
17. Lopez-Bigas N, Audit B, Ouzounis C, Parra G, Guigo R (2005) Are splicing mutations the most frequent cause of hereditary disease? FEBS Lett 579(9):1900-1903 (Pubitemid 40404028)
18. Venables JP, Klinck R, Koh C, Gervais-Bird J, Bramard A, Inkel L, Durand M, Couture S, Froehlich U, Lapointe E, Lucier JF, Thibault P, Rancourt C, Tremblay K, Prinos P, Chabot B, Elela SA (2009) Cancer-associated regulation of alternative splicing. Nat Struct Mol Biol 16(6):670-676
19. Li HR, Wang-Rodriguez J, Nair TM, Yeakley JM, Kwon YS, Bibikova M, Zheng C, Zhou L, Zhang K, Downs T, Fu XD, Fan JB (2006) Two-dimensional transcriptome profiling: identification of messenger RNA isoform signatures in prostate cancer from archived paraffin-embedded cancer specimens. Cancer Res 66(8):4079-4088
20. Zhang M, Gish W (2006) Improved spliced alignment from an information theoretic approach. Bioinformatics 22(1):13-20 (Pubitemid 43057003)
21. Theodoropoulos G, Carraway KL (2007) Molecular signaling in the regulation of mucins. J Cell Biochem 102(5):1103-1116 (Pubitemid 350220032)
22. Vlad AM, Kettel JC, Alajez NM, Carlos CA, Finn OJ (2004) MUC1 immunobiology: from discovery to clinical applications. Adv Immunol 82:249-293 (Pubitemid 38209513)
23. Ligtenberg MJ, Kruijshaar L, Buijs F, van Meijer M, Litvinov SV, Hilkens J (1992) Cell-associated episialin is a complex containing two proteins derived from a common precursor. J Biol Chem 267(9):6171-6177
24. Fontenot JD, Finn OJ, Dales N, Andrews PC, Montelaro RC (1993) Synthesis of large multideterminant peptide immunogens using a poly-proline beta-turn helix motif. Pept Res 6(6):330-336 (Pubitemid 2025330)
25. Fontenot JD, Tjandra N, Bu D, Ho C, Montelaro RC, Finn OJ (1993) Biophysical characterization of one-, two-, and three-tandem repeats of human mucin (muc-1) protein core. Cancer Res 53(22):5386-5394 (Pubitemid 23342155)
26. Fukuda M (2002) Roles of mucin-type O-glycans in cell adhesion. Biochim Biophys Acta 1573(3):394-405 (Pubitemid 35335450)
27. Hilkens J, Ligtenberg MJ, Vos HL, Litvinov SV (1992) Cell membrane-associated mucins and their adhesion-modulating property. Trends Biochem Sci 17(9):359-363
28. Carlos CA, Dong HF, Howard OM, Oppenheim JJ, Hanisch FG, Finn OJ (2005) Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity. J Immunol 175(3):1628-1635 (Pubitemid 41023065)
29. Kufe DW (2009) Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 9(12):874-885
30. Barnd DL, Lan MS, Metzgar RS, Finn OJ (1989) Specific, major histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 86(18):7159-7163 (Pubitemid 19240884)
31. Saeland E, van Vliet SJ, Backstrom M, van den Berg VC, Geijtenbeek TB, Meijer GA, van Kooyk Y (2007) The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma. Cancer Immunol Immunother 56(8):1225-1236 (Pubitemid 46763937)
32. Ren J, Raina D, Chen W, Li G, Huang L, Kufe D (2006) MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling. Mol Cancer Res 4(11):873-883 (Pubitemid 44877017)
33. Mahanta S, Fessler SP, Park J, Bamdad C (2008) A minimal fragment of MUC1 mediates growth of cancer cells. PLoS One 3(4):e2054 (Pubitemid 352025042)
34. Ren J, Li Y, Kufe D (2002) Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling. J Biol Chem 277(20):17616-17622 (Pubitemid 34967564)
35. Wei X, Xu H, Kufe D (2005) Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell 7(2):167-178 (Pubitemid 40248342)
36. Ramasamy S, Duraisamy S, Barbashov S, Kawano T, Kharbanda S, Kufe D (2007) The MUC1 and galectin-3 oncoproteins function in a microRNA-dependent regulatory loop. Mol Cell 27(6):992-1004 (Pubitemid 47488189)
37. Levitin F, Baruch A, Weiss M, Stiegman K, Hartmann ML, Yoeli-Lerner M, Ziv R, Zrihan-Licht S, Shina S, Gat A, Lifschitz B, Simha M, Stadler Y, Cholostoy A, Gil B, Greaves D, Keydar I, Zaretsky J, Smorodinsky N, Wreschner DH (2005) A novel protein derived from the MUC1 gene by alternative splicing and frameshifting. J Biol Chem 280(11):10655-10663 (Pubitemid 40395927)
38. Baruch A, Hartmann M, Zrihan-Licht S, Greenstein S, Burstein M, Keydar I, Weiss M, Smorodinsky N, Wreschner DH (1997) Preferential expression of novel MUC1 tumor antigen isoforms in human epithelial tumors and their tumor-potentiating function. Int J Cancer 71(5):741-749 (Pubitemid 27237193)
39. Rubinstein DB, Karmely M, Ziv R, Benhar I, Leitner O, Baron S, Katz BZ, Wreschner DH (2006) MUC1/X protein immunization enhances cDNA immunization in generating anti-MUC1 alpha/beta junction antibodies that target malignant cells. Cancer Res 66(23):11247-11253 (Pubitemid 46009953)
40. Oosterkamp HM, Scheiner L, Stefanova MC, Lloyd KO, Finstad CL (1997) Comparison of MUC-1 mucin expression in epithelial and non-epithelial cancer cell lines and demonstration of a new short variant form (MUC-1/Z). Int J Cancer 72(1):87-94 (Pubitemid 27314644)
41. Rowse GJ, Tempero RM, VanLith ML, Hollingsworth MA, Gendler SJ (1998) Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model. Cancer Res 58(2):315-321 (Pubitemid 28047073)
42. Dinulescu DM, Ince TA, Quade BJ, Shafer SA, Crowley D, Jacks T (2005) Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer. Nat Med 11(1):63-70 (Pubitemid 40215839)
43. Budiu RA, Mantia-Smaldone G, Elishaev E, Chu T, Thaller J, McCabe K, Lenzner D, Edwards RP, Vlad AM (2011) Soluble MUC1 and serum MUC1-specific antibodies are potential prognostic biomarkers for platinum-resistant ovarian cancer. Cancer Immunol Immunother 60(7):975-984
44. Lesche R, Groszer M, Gao J, Wang Y, Messing A, Sun H, Liu X, Wu H (2002) Cre/loxP-mediated inactivation of the murine Pten tumor suppressor gene. Genesis 32(2):148-149 (Pubitemid 34211723)
45. Budiu RA, Diaconu I, Chrissluis R, Dricu A, Edwards RP, Vlad AM (2009) A conditional mouse model for human MUC1-positive endometriosis shows the presence of anti-MUC1 antibodies and Foxp3+ regulatory T cells. Disease Models Mech 2(11-12):593-603
46. Cartegni L, Chew SL, Krainer AR (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3(4):285-298 (Pubitemid 34279797)
47. Correa I, Plunkett T, Vlad A, Mungul A, Candelora-Kettel J, Burchell JM, Taylor-Papadimitriou J, Finn OJ (2003) Form and pattern of MUC1 expression on T cells activated in vivo or in vitro suggests a function in T-cell migration. Immunology 108(1):32-41 (Pubitemid 36110862)
48. Agrawal B, Krantz MJ, Parker J, Longenecker BM (1998) Expression of MUC1 mucin on activated human T cells: implications for a role of MUC1 in normal immune regulation. Cancer Res 58(18):4079-4081 (Pubitemid 28440559)
49. Fattorossi A, Battaglia A, Malinconico P, Stoler A, Andreocci L, Parente D, Coscarella A, Maggiano N, Perillo A, Pierelli L, Scambia G (2002) Constitutive and inducible expression of the epithelial antigen MUC1 (CD227) in human T cells. Exp Cell Res 280(1):107-118 (Pubitemid 35230372)
50. Ligtenberg MJ, Gennissen AM, Vos HL, Hilkens J (1991) A single nucleotide polymorphism in an exon dictates allele dependent differential splicing of episialin mRNA. Nucleic Acids Res 19(2):297-301 (Pubitemid 21896972)
51. Ng W, Loh AX, Teixeira AS, Pereira SP, Swallow DM (2008) Genetic regulation of MUC1 alternative splicing in human tissues. Br J Cancer 99(6):978-985
52. Roberts GC, Smith CW (2002) Alternative splicing: combinatorial output from the genome. Curr Opin Chem Biol 6(3):375-383 (Pubitemid 34522065)
53. Zhu J, Shendure J, Mitra RD, Church GM (2003) Single molecule profiling of alternative pre-mRNA splicing. Science 301(5634):836-838 (Pubitemid 36962625)
54. Zhang XH, Chasin LA (2004) Computational definition of sequence motifs governing constitutive exon splicing. Genes Dev 18(11):1241-1250 (Pubitemid 38720592)
55. McCarthy EM, Phillips JA 3rd (1998) Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA. Hum Mol Genet 7(9):1491-1496 (Pubitemid 28429931)
56. Ule J, Stefani G, Mele A, Ruggiu M, Wang X, Taneri B, Gaasterland T, Blencowe BJ, Darnell RB (2006) An RNA map predicting Nova-dependent splicing regulation. Nature 444(7119):580-586 (Pubitemid 44864431)
57. Lian Y, Garner HR (2005) Evidence for the regulation of alternative splicing via complementary DNA sequence repeats. Bioinformatics 21(8):1358-1364 (Pubitemid 40542685)
58. Eperon LP, Estibeiro JP, Eperon IC (1986) The role of nucleotide sequences in splice site selection in eukaryotic pre-messenger RNA. Nature 324(6094):280-282 (Pubitemid 17180460)
59. Thompson-Jager S, Domdey H (1987) Yeast pre-mRNA splicing requires a minimum distance between the 5′ splice site and the internal branch acceptor site. Mol Cell Biol 7(11):4010-4016
60. Carson DD (2008) The cytoplasmic tail of MUC1: a very busy place. Sci Signal 1(27):35
61. Jia Y, Persson C, Hou L, Zheng Z, Yeager M, Lissowska J, Chanock SJ, Chow WH, Ye W (2010) A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer. Cancer Causes Control 21(2):313-321
62. Xu Q, Yuan Y, Sun LP, Gong YH, Xu Y, Yu XW, Dong NN, Lin GD, Smith PN, Li RW (2009) Risk of gastric cancer is associated with the MUC1 568 A/G polymorphism. Int J Oncol 35(6):1313-1320
63. David CJ, Manley JL (2010) Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev 24(21):2343-2364